Search

Your search keyword '"Al-Ali, Haifa Kathrin"' showing total 611 results
Start Over Author "Al-Ali, Haifa Kathrin"
Sorry, I don't understand your search. ×
611 results on '"Al-Ali, Haifa Kathrin"'

1. FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)

Author

Isfort, Susanne, von Bubnoff, Nikolas, Al-Ali, Haifa Kathrin, Becker, Heiko, Götze, Thorsten, le Coutre, Philipp, Griesshammer, Martin, Moskwa, Claudia, Wohn, Luisa, Riedel, Johanna, Palandri, Francesca, Manz, Kirsi, Hochhaus, Andreas, Döhner, Konstanze, and Heidel, Florian H.

Published
2024
Full Text
View/download PDF

2. ROP-ET: a prospective phase III trial investigating the efficacy and safety of ropeginterferon alfa-2b in essential thrombocythemia patients with limited treatment options

Author

Kiladjian, Jean-Jacques, Marin, Francisca Ferrer, Al-Ali, Haifa Kathrin, Alvarez-Larrán, Alberto, Beggiato, Eloise, Bieniaszewska, Maria, Breccia, Massimo, Buxhofer-Ausch, Veronika, Cerna, Olga, Crisan, Ana-Manuela, Danaila, Catalin Doru, De Stefano, Valerio, Döhner, Konstanze, Empson, Victoria, Gora-Tybor, Joanna, Griesshammer, Martin, Grosicki, Sebastian, Guglielmelli, Paola, García-Gutierrez, Valentin, Heidel, Florian H., Illés, Arpád, Tomuleasa, Ciprian, James, Chloe, Koschmieder, Steffen, Krauth, Maria-Theresa, Krejcy, Kurt, Lazaroiu, Mihaela-Cornelia, Mayer, Jiri, Nagy, Zsolt György, Nicolini, Franck-Emmanuel, Palandri, Francesca, Pappa, Vassiliki, Reiter, Andreas Johannes, Sacha, Tomasz, Schlager, Stefanie, Schmidt, Stefan, Terpos, Evangelos, Unger, Martin, Wölfler, Albert, Cirici, Blanca Xicoy, and Klade, Christoph

Published
2024
Full Text
View/download PDF

4. Efficacy and safety of fedratinib in patients with myelofibrosis previously treated with ruxolitinib (FREEDOM2): results from a multicentre, open-label, randomised, controlled, phase 3 trial

Author

Harrison, Claire N, Mesa, Ruben, Talpaz, Moshe, Al-Ali, Haifa Kathrin, Xicoy, Blanca, Passamonti, Francesco, Palandri, Francesca, Benevolo, Giulia, Vannucchi, Alessandro Maria, Mediavilla, Clemence, Iurlo, Alessandra, Kim, InHo, Rose, Shelonitda, Brown, Patrick, Hernandez, Christopher, Wang, Jia, and Kiladjian, Jean-Jacques

Published
2024
Full Text
View/download PDF

5. Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study

Author

Isfort, Susanne, Manz, Kirsi, Teichmann, Lino L., Crysandt, Martina, Burchert, Andreas, Hochhaus, Andreas, Saussele, Susanne, Kiani, Alexander, Göthert, Joachim R., Illmer, Thomas, Schafhausen, Philippe, Al-Ali, Haifa Kathrin, Stegelmann, Frank, Hänel, Mathias, Pfeiffer, Tim, Giagounidis, Aristoteles, Franke, Georg-Nikolaus, Koschmieder, Steffen, Fabarius, Alice, Ernst, Thomas, Warnken-Uhlich, Mareille, Wolber, Uta, Kohn, Denise, Pfirrmann, Markus, Wolf, Dominik, and Brümmendorf, Tim H.

Published
2023
Full Text
View/download PDF

6. 10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trial

Author

Finke, Jürgen, Schaap, Nicolaas Petrus Michael, Zucenka, Andrius, Metzelder, Stephan, Jost, Edgar, Perić, Zinaida, Forghieri, Fabio, Allione, Bernadino, Martelli, Maurizio, Iori, Anna Paola, Wittnebel, Sebastian, Mengarelli, Andrea, Imovilli, Annalisa, Olivieri, Attilio, De Prijck, Bernard José Marie, van der Poel, Marjolein W.M., Junghanß, Christian, Salih, Helmut Rainer, Tafuri, Agostino, Guimarães, José Eduardo, Musso, Maurizio, De Fabritiis, Paolo, Chevallier, Patrice, Selleslag, Dominik Luc, Cascavilla, Nicola, Berneman, Zwi, Jaspers, Aurélie, Zuffa, Eliana, Vanstraelen, Gaëtan, Visani, Giuseppe, Cuijpers, Maria Louisa Henriëtte, De Becker, Ann, Mianulli, Anna Maria, Hackanson, Björn, Mihaylov, Georgi Georgiev, Martinelli, Giovanni, Paolini, Stefania, Zinzani, Pier Luigi, Henkes, Martin, Al-Ali, Haifa Kathrin, La Rosée, Paul, Chierichini, Anna, Cudillo, Laura, Specchia, Giorgina, Šimec, Njetočka Gredelj, Capalbo, Silvana Franca, Spinosa, Giuseppina, Molica, Stefano, de Jonge-Peeters, Susan Dorothé, Lübbert, Michael, Wijermans, Pierre W, Kicinski, Michal, Chantepie, Sylvain, Van der Velden, Walter J F M, Noppeney, Richard, Griškevičius, Laimonas, Neubauer, Andreas, Crysandt, Martina, Vrhovac, Radovan, Luppi, Mario, Fuhrmann, Stephan, Audisio, Ernesta, Candoni, Anna, Legrand, Olivier, Foà, Robin, Gaidano, Gianluca, van Lammeren-Venema, Danielle, Posthuma, Eduardus F M, Hoogendoorn, Mels, Giraut, Anne, Stevens-Kroef, Marian, Jansen, Joop H, de Graaf, Aniek O, Efficace, Fabio, Ammatuna, Emanuele, Vilque, Jean-Pierre, Wäsch, Ralph, Becker, Heiko, Blijlevens, Nicole, Dührsen, Ulrich, Baron, Frédéric, Suciu, Stefan, Amadori, Sergio, Venditti, Adriano, and Huls, Gerwin

Published
2023
Full Text
View/download PDF

7. Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study

Author

Niederwieser, Dietger, Lang, Thomas, Krahl, Rainer, Heinicke, Thomas, Maschmeyer, Georg, Al-Ali, Haifa Kathrin, Schwind, Sebastian, Jentzsch, Madlen, Cross, Michael, Kahl, Christoph, Wolf, Hans-Heinrich, Sayer, Herbert, Schulze, Antje, Dreger, Peter, Hegenbart, Ute, Krämer, Alwin, Junghanss, Christian, Mügge, Lars-Olof, Hähling, Detlev, Hirt, Carsten, Späth, Christian, Peter, Norma, Opitz, Bernhard, Florschütz, Axel, Reifenrath, Kolja, Zojer, Niklas, Scholl, Sebastian, Pönisch, Wolfram, Heyn, Simone, Vucinic, Vladan, Hochhaus, Andreas, Aul, Carlo, Giagounidis, Aristoteles, Balleisen, Leopold, Oldenkott, Bernd, Staib, Peter, Kiehl, Michael, Schütte, Wolfgang, Naumann, Ralph, Eimermacher, Hartmut, Dörken, Bernd, Sauerland, Cristina, Lengfelder, Eva, Hiddemann, Wolfgang, Wörmann, Bernhard, Müller-Tidow, Carsten, Serve, Hubert, Schliemann, Christoph, Hehlmann, Rüdiger, Berdel, Wolfgang E., Pfirrmann, Markus, Krug, Utz, and Hoffmann, Verena S.

Published
2023
Full Text
View/download PDF

8. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis previously treated with a JAK inhibitor (MOMENTUM): an updated analysis of an international, double-blind, randomised phase 3 study

Author

Gerds, Aaron T, Verstovsek, Srdan, Vannucchi, Alessandro M, Al-Ali, Haifa Kathrin, Lavie, David, Kuykendall, Andrew T, Grosicki, Sebastian, Iurlo, Alessandra, Goh, Yeow Tee, Lazaroiu, Mihaela C, Egyed, Miklos, Fox, Maria Laura, McLornan, Donal, Perkins, Andrew, Yoon, Sung-Soo, Gupta, Vikas, Kiladjian, Jean-Jacques, Granacher, Nikki, Lee, Sung-Eun, Ocroteala, Luminita, Passamonti, Francesco, Harrison, Claire N, Oh, Stephen, Klencke, Barbara J, Yu, Jing, Donahue, Rafe, Kawashima, Jun, and Mesa, Ruben

Published
2023
Full Text
View/download PDF

11. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Author

Abulafia, Adi Shacham, Al-Ali, Haifa Kathrin, Andreasson, Bjorn, Angona, Anna, Ayala, Rosa, Bang, Soo-Mee, Bank, Bruce, Barraco, Fiorenza, Beggiato, Eloise, Benghiat, Fleur Samantha, Bonifacio, MassimiliaNo, Bories, Claire, Borsaru, Gabriela, Brabrand, Mette, Braester, Andrei, Broliden, Andes, Buxhofer-Ausch, Veronika, Cambier, Nathalie, Caramella, Marianna, Carpentier, Benjamin, Cascavilla, Nicola, Castellano, Maria Giraldo, Chang, Hung, Chen, Chih-Cheng, Cheong, June-Won, Choi, Yunsuk, Choi, Philip, Corsetti, Maria Teresa, Cuadrado, Isabel Montero, Cunningham, Julia, Damaj, Gandhi Laurent, De Stefano, Valerio, Delage, Robert, Delgado, Regina Garcĺa, Diaz, Jose Miguel Torregrosa, Dombi, Péter, Dubruille, Viviane, Egyed, Miklós, El Fassi, Daniel, Elinder-Camburn, Anna, Elli, Elena Maria, Ellis, Martin, Fava, Carmen, Fazal, Salman, Fleischman, Angela, Foltz, Lynda, Fox, Laura, Gabrail, Nashat, Garcĺa-Gutiérrez, Jose Valentĺn, Gerds, Aaron, Girault, Stephane, Gisslinger, Heinz, Gluvacov, Alexandru, Goh, Yeow Tee, Göthert, Joachim, Granacher, Nikki, Grosicki, Sebastian, Gupta, Vikas, Hadjiev (Hadzhiev), Evgeni (Evgueniy), Hafraoui, Kaoutar, Hamed, Aryan, Harrison, Claire, Hasselbalch, Hans, Hauser, Hanns, Heaney, Mark, Hebart, Holger, Hernandez Rivas, Jesus Maria, Higuero Saavedra, Victor, Hillis, Christopher, Hou, Hsin-An, How, Jonathan, Huang, Daniel, Hus, Marek, Illés, Arpad, Isidori, Alessandro, Iurlo, Alessandra, Ivanov, Vadim, Johansson, Peter, Jung, Chul Won, Kiladjian, Jean-Jacques, Kirgner, Ilya, Koren-Michowitz, Maya, Koschmieder, Steffen, Kosztolanyi, Szabolcs Ors, Kreiniz, Natalia, Kuykendall, Andrew, Lambert, Jonathan, Laribi, Kamel, Lascaux, Axelle, Lavie, Noa, Lavie, David, Lazaroiu, Mihaela, Leahy, Michael, Lech-Maranda, Ewa, Lee, Sung-Eun, Lee, Won Sik, Legrand, Ollivier, Lemoli, Roberto, Liang, James, Lim, Sung-Nam, Loschi, Michael, Lucchesi, Alessandro, Macarie, Ioan, Marolleau, Jean-Pierre, Martelli, Maurizio, Mayer, Jiri, McCloskey, James, McDermott, Christopher, McLornan, Donal, McMahon, Brandon, Mehta, Priyanka, Mesa, Ruben, Mikala, Gábor, Milojkovic, Dragana, Mineur, Philippe, Mishchenko, Elena, Moon, Joon Ho, Nagy, Zsolt, Narayanan, Srinivasan, O'Connell, Casey, Ocroteala, Luminita, Oh, Stephen, Ojeda-Uribe, Mario, Ong, Kiat Hoe, Otegbeye, Folashade, Palmer, Jeanne, Pane, Fabrizio, Passamonti, Francesco, Patriarca, Andrea, Perkins, Andrew, Pietrantuono, Giuseppe, Plander, Mark, Platzbecker, Uwe, Prasad, Ritam, Prejzner, Witold, Rachow, Tobias, Radinoff, Atanas, Rejtő, László, Rinaldi, Ciro, Robak, Tadeusz, Rodriguez, Maria Angeles Fernandez, Ronson, Aaron, Ross, David, Sacha, Tomasz, Sadjadian, Parvis, Salar, Antonio, Santillana, Guillermo Sanz, Scheid, Christof, Schmidt, Aline, Severinsen, Marianne Tang, Stoeva, Vera, Szwedyk, Paweł, Tiribelli, Mario, Trautmann-Grill, Karolin, Trottier, Amy, Tzvetkov, Nikolay, van Droogenbroeck, Janusz, Vannucchi, Alessandro, Verstovsek, Srdan, Vianelli, Nicola, von Bubnoff, Nikolas, Wolf, Dominik, Woszczyk, Dariusz, Woźny, Tomasz, Wróbel, Tomasz, Xicoy, Blanca, Yeh, Su-Peng, Yoon, Sung-Soo, Gerds, Aaron T, Vannucchi, Alessandro M, Kuykendall, Andrew T, Lazaroiu, Mihaela C, Egyed, Miklos, Fox, Maria Laura, Harrison, Claire N, Klencke, Barbara J, Ro, Sunhee, Donahue, Rafe, and Kawashima, Jun

Published
2023
Full Text
View/download PDF

12. Prognostic impact of the bone marrow tumor microenvironment, HLA-I and HLA-Ib expression in MDS and CMML progression to sAML.

Author

Bauer, Marcus, Jäkel, Nadja, Wilfer, Andreas, Haak, Anja, Eszlinger, Markus, Kelemen, Katalin, Haemmerle, Monika, Al-Ali, Haifa Kathrin, Seliger, Barbara, and Wickenhauser, Claudia

Abstract

Genetic aberrations and immune escape are fundamental in MDS and CMML initiation and progression to sAML. Therefore, quantitative and spatial immune cell organization, expression of immune checkpoints (ICP), classical human leukocyte antigen class I (HLA-I) and the non-classical HLA-Ib antigens were analyzed in 274 neoplastic and 50 non-neoplastic bone marrow (BM) biopsies using conventional and multiplex immunohistochemistry and correlated to publicly available dataset. Higher numbers of tissue infiltrating lymphocytes (TILs) were found in MDS/CMML (8.8%) compared to sAML (7.5%) and non-neoplastic BM (5.3%). Higher T cell abundance, including the CD8+ T cell subset, inversely correlated with the number of pathogenic mutations and was associated with blast BM counts, ICP expression, spatial T cell distribution and improved patients' survival in MDS and CMML. In MDS/CMML, higher PD-1/PD-L1/PD-L2 and HLA-I, but lower HLA-G expression correlated with a significantly better patients' outcome. Moreover, a closer spatial proximity of T cell subpopulations and their proximity to myeloid blasts showed a stronger prognostic impact when compared to TIL numbers. In sAML – the continuum of MDS and CMML – the number of TILs had no impact on prognosis, but higher CD28 and HLA-I expression correlated with a better outcome of sAML patients. This study underlines the independent prognostic value of the tumor microenvironment in MDS/CMML progression to sAML, which shows the most pronounced immune escape. Moreover, new prognostic markers, like HLA-G expression and spatial T cell distribution, were described for the first time, which might also serve as therapeutic targets. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

14. Breakthrough infections in MPN-COVID vaccinated patients

Author

Barbui, Tiziano, Carobbio, Alessandra, Ghirardi, Arianna, Iurlo, Alessandra, De Stefano, Valerio, Sobas, Marta Anna, Rumi, Elisa, Elli, Elena Maria, Lunghi, Francesca, Gasior Kabat, Mercedes, Cuevas, Beatriz, Guglielmelli, Paola, Bonifacio, Massimiliano, Marchetti, Monia, Alvarez-Larran, Alberto, Fox, Laura, Bellini, Marta, Daffini, Rosa, Benevolo, Giulia, Carreno-Tarragona, Gonzalo, Patriarca, Andrea, Al-Ali, Haifa Kathrin, Andrade-Campos, Maria Marcio Miguel, Palandri, Francesca, Harrison, Claire, Foncillas, Maria Angeles, Osorio, Santiago, Koschmieder, Steffen, Magro Mazo, Elena, Kiladjian, Jean-Jacques, Bolaños Calderón, Estefanía, Heidel, Florian H., Quiroz Cervantes, Keina, Griesshammer, Martin, Garcia-Gutierrez, Valentin, Sanchez, Alberto Marin, Hernandez-Boluda, Juan Carlos, Lopez Abadia, Emma, Carli, Giuseppe, Sagues Serrano, Miguel, Kusec, Rajko, Xicoy Cirici, Blanca, Guenova, Margarita, Navas Elorza, Begona, Angona, Anna, Cichocka, Edyta, Kulikowska de Nałęcz, Anna, Cattaneo, Daniele, Bucelli, Cristina, Betti, Silvia, Borsani, Oscar, Cavalca, Fabrizio, Carbonell, Sara, Curto-Garcia, Natalia, Benajiba, Lina, Rambaldi, Alessandro, and Vannucchi, Alessandro Maria

Published
2022
Full Text
View/download PDF

15. Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15

Author

Hell, Saskia, Jentzsch, Madlen, Franke, Georg-Nikolaus, Jäkel, Nadja, Schulze, Susann, Edelmann, Jeanett, Nenoff, Kolja, Grieb, Nora, Jeremic, Veljko, Cross, Michael, Leiblein, Sabine, Bach, Enrica, Pönisch, Wolfram, Al-Ali, Haifa-Kathrin, Schwind, Sebastian, Platzbecker, Uwe, Lange, Thoralf, Niederwieser, Dietger, and Vucinic, Vladan

Published
2022
Full Text
View/download PDF

17. Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

Author

Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, and Al-Ali, Haifa Kathrin

Published
2021
Full Text
View/download PDF

18. Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

Author

Heinicke, Thomas, Krahl, Rainer, Kahl, Christoph, Cross, Michael, Scholl, Sebastian, Wolf, Hans-Heinrich, Hähling, Detlev, Hegenbart, Ute, Peter, Norma, Schulze, Antje, Florschütz, Axel, Schmidt, Volker, Reifenrath, Kolja, Zojer, Niklas, Junghanss, Christian, Sayer, Herbert G., Maschmeyer, Georg, Späth, Christian, Hochhaus, Andreas, Fischer, Thomas, Al-Ali, Haifa Kathrin, and Niederwieser, Dietger

Published
2021
Full Text
View/download PDF

19. Association of immune evasion in myeloid sarcomas with disease manifestation and patients' survival.

Author

Bauer, Marcus, Monecke, Astrid, Hackl, Hubert, Wilfer, Andreas, Jaekel, Nadja, Bläker, Hendrik, Al-Ali, Haifa Kathrin, Seliger, Barbara, and Wickenhauser, Claudia

Subjects
HISTOCOMPATIBILITY class I antigens, MYELOID sarcoma, GENE expression, MULTISPECTRAL imaging, RNA sequencing
Abstract

Introduction: Myeloid sarcomas (MS) comprise rare extramedullary manifestations of myeloid neoplasms with poor patients' outcome. While the clinical relevance of the tumor microenvironment (TME) is well established in many malignancies, there exists limited information in MS. Methods: The expression of the human leukocyte antigen class I (HLA-I) antigens, HLA-I antigen processing and presenting machinery (APM) components and the composition of the TME of 45 MS and paired bone marrow (BM) samples from two independent cohorts were assessed by immunohistochemistry, multispectral imaging, and RNA sequencing (RNAseq). Results: A significant downregulation of the HLA-I heavy chain (HC; 67.5%) and ß2-microglobulin (ß2M; 64.8%), but an upregulation of HLA-G was found in MS compared to BM samples, which was confirmed in a publicly available dataset. Moreover, MS tumors showed a predominantly immune cell excluded TME with decreased numbers of tissue infiltrating lymphocytes (TILs) (9.5%) compared to paired BM (22.9%). RNAseq analysis of a subset of 10 MS patients with preserved and reduced HLA-I HC expression revealed 150 differentially expressed genes and a significantly reduced expression of inflammatory response genes was found in samples with preserved HLA-I expression. Furthermore, low HLA-I expression and low TIL numbers in the TME of MS cases were linked to an inferior patients' outcome. Discussion: This study demonstrated a high prevalence of immune escape strategies in the pathogenesis and extramedullary spread of MS, which was also found in patients without evidence of any BM pathology, which yields the rational for the development of novel individually tailored therapies for MS patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

21. The Data Registry of the European Competence Network on Mastocytosis (ECNM): Set Up, Projects, and Perspectives

Author

Valent, Peter, Oude Elberink, Joanna N.G., Gorska, Aleksandra, Lange, Magdalena, Zanotti, Roberta, van Anrooij, Björn, Bonifacio, Massimiliano, Bonadonna, Patrizia, Gleixner, Karoline V., Hadzijusufovic, Emir, Perkins, Cecelia, Hartmann, Karin, Illerhaus, Anja, Merante, Serena, Elena, Chiara, Shoumariyeh, Khalid, von Bubnoff, Nikolas, Parente, Roberta, Triggiani, Massimo, Schwaab, Juliana, Jawhar, Mohamad, Caroppo, Francesca, Fortina, Anna Belloni, Brockow, Knut, David Fuchs, Greul, Rosemarie, Yavuz, Akif Selim, Doubek, Michael, Mattsson, Mattias, Hagglund, Hans, Panse, Jens, Sabato, Vito, Aberer, Elisabeth, Al-Ali, Haifa Kathrin, Morren, Marie-Anne, Varkonyi, Judit, Zink, Alexander, Niedoszytko, Marek, Niederwieser, Dietger, Malcovati, Luca, Reiter, Andreas, Kennedy, Vanessa, Gotlib, Jason, Lortholary, Olivier, Hermine, Olivier, Arock, Michel, Kluin-Nelemans, Hanneke, and Sperr, Wolfgang R.

Published
2019
Full Text
View/download PDF

22. MPN-478 MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor

Author

Mesa, Ruben, Gerds, Aaron, Vannucchi, Alessandro, Al-Ali, Haifa Kathrin, Lavie, David, Kuykendall, Andrew, Grosicki, Sebastian, Iurlo, Alessandra, Goh, Yeow Tee, Lazaroiu, Mihaela, Egyed, Miklos, Fox, Maria Laura, McLornan, Donal, Perkins, Andrew, Yoon, Sung-Soo, Gupta, Vikas, Kiladjian, Jean-Jacques, Donahue, Rafe, Kawashima, Jun, and Verstovsek, Srdan

Published
2022
Full Text
View/download PDF

23. MPN-483 Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) [MOMENTUM]

Author

Gerds, Aaron, Verstovsek, Srdan, Vannucchi, Alessandro, Al-Ali, Haifa Kathrin, Lavie, David, Kuykendall, Andrew, Grosicki, Sebastian, Iurlo, Alessandra, Goh, Yeow Tee, Lazaroiu, Mihaela, Egyed, Miklos, Fox, Maria Laura, McLornan, Donal, Perkins, Andrew, Yoon, Sung-Soo, Gupta, Vikas, Kiladjian, Jean-Jacques, Donahue, Rafe, Kawashima, Jun, and Mesa, Ruben

Published
2022
Full Text
View/download PDF

24. Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials

Author

Heinicke, Thomas, Krahl, Rainer, Kahl, Christoph, Cross, Michael, Scholl, Sebastian, Wolf, Hans‑Heinrich, Hähling, Detlev, Hegenbart, Ute, Peter, Norma, Schulze, Antje, Florschütz, Axel, Schmidt, Volker, Reifenrath, Kolja, Zojer, Niklas, Junghanss, Christian, Sayer, Herbert G., Maschmeyer, Georg, Späth, Christian, Hochhaus, Andreas, Fischer, Thomas, Al‑Ali, Haifa Kathrin, and Niederwieser, Dietger

Published
2021
Full Text
View/download PDF

25. Physical exercise recommendations for patients with polycythemia vera based on preferences identified in a large international patient survey study of the East German Study Group for Hematology and Oncology (OSHO #97)

Author

Felser, Sabine, primary, Rogahn, Julia, additional, Hollenbach, Lina, additional, Gruen, Julia, additional, le Coutre, Philipp, additional, Al‐Ali, Haifa Kathrin, additional, Schulze, Susann, additional, Muegge, Lars‐Olof, additional, Kraze‐Kliebhahn, Veronika, additional, and Junghanss, Christian, additional

Published
2023
Full Text
View/download PDF

26. S214: DISEASE-MODIFYING ACTIVITY OF NAVTEMADLIN (NVTM) CORRELATED WITH SURVIVAL OUTCOMES IN JANUS KINASE INHIBITOR (JAKI) RELAPSED OR REFRACTORY (R/R) MYELOFIBROSIS (MF) PATIENTS (PTS)

Author

Vachhani, Pankit, primary, Perkins, Andrew, additional, Mascarenhas, John, additional, Al-Ali, Haifa Kathrin, additional, Kiladjian, Jean-Jacques, additional, Cerquozzi, Sonia, additional, Dybko, Jaroslaw, additional, Delgado, Regina Garcia, additional, Rivas, Jesus Hernández, additional, Hebart, Holger, additional, Huang, Zhuying, additional, Krejsa, Cecile, additional, Qamoos, Hope, additional, Mcgreivy, Jesse, additional, Rothbaum, Wayne P., additional, Verstovsek, Srdan, additional, and Vannucchi, Alessandro, additional

Published
2023
Full Text
View/download PDF

28. PB1887: STING AGONIST FOR THE TREATMENT OF RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA AND HIGH-RISK MYELODYSPLASTIC SYNDROME: A FIRST-IN-CLINIC PHASE 1 STUDY OF GSK3745417

Author

Montesinos, Pau, primary, Al-Ali, Haifa Kathrin, additional, Dominguez, Juan Manuel Alonso, additional, Jentzsch, Madlen, additional, Lavrencic, Mojca, additional, Martelli, Maria Paola, additional, Röllig, Christoph, additional, Sica, Simona, additional, Riham, Iadevaia, additional, Yablonski, Kaitlin, additional, Wang, Tianli, additional, Mahmood, Zafar, additional, Koenen, Giedre, additional, Schmidt, Hank, additional, Yang, Jingsing, additional, and Yee, Karen, additional

Published
2023
Full Text
View/download PDF

29. S213: BMS-986158, A POTENT BET INHIBITOR, AS MONOTHERAPY AND IN COMBINATION WITH RUXOLITINIB OR FEDRATINIB IN INTERMEDIATE- OR HIGH-RISK MYELOFIBROSIS (MF): RESULTS FROM A PHASE 1/2 STUDY

Author

Ayala, Rosa, primary, Lopez, Nieves, additional, Abulafia, Adi Shacham, additional, Alwan, Maan, additional, Yannakou, Costas K., additional, Raman, Indu, additional, Ribrag, Vincent, additional, Fong, Chun Yew, additional, Volchek, Yulia, additional, Bonifacio, Massimiliano, additional, Tucci, Alessandra, additional, Kiladjian, Jean-Jacques, additional, Rivas, Jésus Marïa Hernandez, additional, Xicoy, Blanca, additional, Al-Ali, Haifa Kathrin, additional, Ianotto, Jean-Christope, additional, Lee-Hoeflich, Si Tuen, additional, Das, Sharmilla, additional, Wu, Bin, additional, Ravindran, Palanikumar, additional, Zhao, Qian, additional, Wang, Guan, additional, Esposito, Oriana, additional, Liu, Yu, additional, Nikolova, Zariana, additional, Tehlirian, Christopher, additional, Coker, Shodeinde, additional, and Lavie, David, additional

Published
2023
Full Text
View/download PDF

31. Correction: Efficacy and safety of a novel dosing strategy for ruxolitinib in the treatment of patients with myelofibrosis and anemia: the REALISE phase 2 study

Author

Cervantes, Francisco, Ross, David M., Radinoff, Atanas, Palandri, Francesca, Myasnikov, Alexandr, Vannucchi, Alessandro M., Zachee, Pierre, Gisslinger, Heinz, Komatsu, Norio, Foltz, Lynda, Mannelli, Francesco, Passamonti, Francesco, Gilotti, Geralyn, Sadek, Islam, Tiwari, Ranjan, Zor, Evren, and Al-Ali, Haifa Kathrin

Published
2021
Full Text
View/download PDF

35. Activity of decitabine combined with all-trans retinoic acid in oligoblastic acute myeloid leukemia: results from a randomized 2x2 phase II trial (DECIDER)

Author

Rummelt, Christoph, primary, Grishina, Olga, additional, Schmoor, Claudia, additional, Crysandt, Martina, additional, Heuser, Michael, additional, Götze, Katharina S., additional, Schlenk, Richard F., additional, Döhner, Konstanze, additional, Salih, Helmut R., additional, Heil, Gerhard, additional, Müller-Tidow, Carsten, additional, Brugger, Wolfram, additional, Kündgen, Andrea, additional, De Wit, Maike, additional, Giagounidis, Aristoteles, additional, Scholl, Sebastian, additional, Neubauer, Andreas, additional, Krauter, Jürgen, additional, Bug, Gesine, additional, Al-Ali, Haifa Kathrin, additional, Wäsch, Ralph, additional, Becker, Heiko, additional, May, Annette M., additional, Duyster, Justus, additional, Hackanson, Björn, additional, Ganser, Arnold, additional, Döhner, Hartmut, additional, and Lübbert, Michael, additional

Published
2023
Full Text
View/download PDF

36. Anxieties, age and motivation influence physical activity in patients with myeloproliferative neoplasms - a multicenter survey from the East German study group for hematology and oncology (OSHO #97)

Author

Felser, Sabine, primary, Rogahn, Julia, additional, le Coutre, Philipp, additional, Al-Ali, Haifa Kathrin, additional, Schulze, Susann, additional, Muegge, Lars-Olof, additional, Gruen, Julia, additional, Geissler, Jan, additional, Kraze-Kliebhahn, Veronika, additional, and Junghanss, Christian, additional

Published
2023
Full Text
View/download PDF

37. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study

Author

Verstovsek, Srdan, primary, Gerds, Aaron T, additional, Vannucchi, Alessandro M, additional, Al-Ali, Haifa Kathrin, additional, Lavie, David, additional, Kuykendall, Andrew T, additional, Grosicki, Sebastian, additional, Iurlo, Alessandra, additional, Goh, Yeow Tee, additional, Lazaroiu, Mihaela C, additional, Egyed, Miklos, additional, Fox, Maria Laura, additional, McLornan, Donal, additional, Perkins, Andrew, additional, Yoon, Sung-Soo, additional, Gupta, Vikas, additional, Kiladjian, Jean-Jacques, additional, Granacher, Nikki, additional, Lee, Sung-Eun, additional, Ocroteala, Luminita, additional, Passamonti, Francesco, additional, Harrison, Claire N, additional, Klencke, Barbara J, additional, Ro, Sunhee, additional, Donahue, Rafe, additional, Kawashima, Jun, additional, Mesa, Ruben, additional, Abulafia, Adi Shacham, additional, Andreasson, Bjorn, additional, Angona, Anna, additional, Ayala, Rosa, additional, Bang, Soo-Mee, additional, Bank, Bruce, additional, Barraco, Fiorenza, additional, Beggiato, Eloise, additional, Benghiat, Fleur Samantha, additional, Bonifacio, MassimiliaNo, additional, Bories, Claire, additional, Borsaru, Gabriela, additional, Brabrand, Mette, additional, Braester, Andrei, additional, Broliden, Andes, additional, Buxhofer-Ausch, Veronika, additional, Cambier, Nathalie, additional, Caramella, Marianna, additional, Carpentier, Benjamin, additional, Cascavilla, Nicola, additional, Castellano, Maria Giraldo, additional, Chang, Hung, additional, Chen, Chih-Cheng, additional, Cheong, June-Won, additional, Choi, Yunsuk, additional, Choi, Philip, additional, Corsetti, Maria Teresa, additional, Cuadrado, Isabel Montero, additional, Cunningham, Julia, additional, Damaj, Gandhi Laurent, additional, De Stefano, Valerio, additional, Delage, Robert, additional, Delgado, Regina Garcĺa, additional, Diaz, Jose Miguel Torregrosa, additional, Dombi, Péter, additional, Dubruille, Viviane, additional, Egyed, Miklós, additional, El Fassi, Daniel, additional, Elinder-Camburn, Anna, additional, Elli, Elena Maria, additional, Ellis, Martin, additional, Fava, Carmen, additional, Fazal, Salman, additional, Fleischman, Angela, additional, Foltz, Lynda, additional, Fox, Laura, additional, Gabrail, Nashat, additional, Garcĺa-Gutiérrez, Jose Valentĺn, additional, Gerds, Aaron, additional, Girault, Stephane, additional, Gisslinger, Heinz, additional, Gluvacov, Alexandru, additional, Göthert, Joachim, additional, Hadjiev (Hadzhiev), Evgeni (Evgueniy), additional, Hafraoui, Kaoutar, additional, Hamed, Aryan, additional, Harrison, Claire, additional, Hasselbalch, Hans, additional, Hauser, Hanns, additional, Heaney, Mark, additional, Hebart, Holger, additional, Hernandez Rivas, Jesus Maria, additional, Higuero Saavedra, Victor, additional, Hillis, Christopher, additional, Hou, Hsin-An, additional, How, Jonathan, additional, Huang, Daniel, additional, Hus, Marek, additional, Illés, Arpad, additional, Isidori, Alessandro, additional, Ivanov, Vadim, additional, Johansson, Peter, additional, Jung, Chul Won, additional, Kirgner, Ilya, additional, Koren-Michowitz, Maya, additional, Koschmieder, Steffen, additional, Kosztolanyi, Szabolcs Ors, additional, Kreiniz, Natalia, additional, Kuykendall, Andrew, additional, Lambert, Jonathan, additional, Laribi, Kamel, additional, Lascaux, Axelle, additional, Lavie, Noa, additional, Lazaroiu, Mihaela, additional, Leahy, Michael, additional, Lech-Maranda, Ewa, additional, Lee, Won Sik, additional, Legrand, Ollivier, additional, Lemoli, Roberto, additional, Liang, James, additional, Lim, Sung-Nam, additional, Loschi, Michael, additional, Lucchesi, Alessandro, additional, Macarie, Ioan, additional, Marolleau, Jean-Pierre, additional, Martelli, Maurizio, additional, Mayer, Jiri, additional, McCloskey, James, additional, McDermott, Christopher, additional, McMahon, Brandon, additional, Mehta, Priyanka, additional, Mikala, Gábor, additional, Milojkovic, Dragana, additional, Mineur, Philippe, additional, Mishchenko, Elena, additional, Moon, Joon Ho, additional, Nagy, Zsolt, additional, Narayanan, Srinivasan, additional, O'Connell, Casey, additional, Oh, Stephen, additional, Ojeda-Uribe, Mario, additional, Ong, Kiat Hoe, additional, Otegbeye, Folashade, additional, Palmer, Jeanne, additional, Pane, Fabrizio, additional, Patriarca, Andrea, additional, Pietrantuono, Giuseppe, additional, Plander, Mark, additional, Platzbecker, Uwe, additional, Prasad, Ritam, additional, Prejzner, Witold, additional, Rachow, Tobias, additional, Radinoff, Atanas, additional, Rejtő, László, additional, Rinaldi, Ciro, additional, Robak, Tadeusz, additional, Rodriguez, Maria Angeles Fernandez, additional, Ronson, Aaron, additional, Ross, David, additional, Sacha, Tomasz, additional, Sadjadian, Parvis, additional, Salar, Antonio, additional, Santillana, Guillermo Sanz, additional, Scheid, Christof, additional, Schmidt, Aline, additional, Severinsen, Marianne Tang, additional, Stoeva, Vera, additional, Szwedyk, Paweł, additional, Tiribelli, Mario, additional, Trautmann-Grill, Karolin, additional, Trottier, Amy, additional, Tzvetkov, Nikolay, additional, van Droogenbroeck, Janusz, additional, Vannucchi, Alessandro, additional, Verstovsek, Srdan, additional, Vianelli, Nicola, additional, von Bubnoff, Nikolas, additional, Wolf, Dominik, additional, Woszczyk, Dariusz, additional, Woźny, Tomasz, additional, Wróbel, Tomasz, additional, Xicoy, Blanca, additional, and Yeh, Su-Peng, additional

Published
2023
Full Text
View/download PDF

38. International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

Author

Dombret, Hervé, Seymour, John F., Butrym, Aleksandra, Wierzbowska, Agnieszka, Selleslag, Dominik, Jang, Jun Ho, Kumar, Rajat, Cavenagh, James, Schuh, Andre C., Candoni, Anna, Récher, Christian, Sandhu, Irwindeep, Bernal del Castillo, Teresa, Al-Ali, Haifa Kathrin, Martinelli, Giovanni, Falantes, Jose, Noppeney, Richard, Stone, Richard M., Minden, Mark D., McIntyre, Heidi, Songer, Steve, Lucy, Lela M., Beach, C.L., and Döhner, Hartmut

Published
2015
Full Text
View/download PDF

39. Questions arising on phlebotomy in polycythemia vera: prophylactic measures to reduce thromboembolic events require patient-focused decisions

Author

Heidel, Florian H., Al-Ali, Haifa-Kathrin, Hirt, Carsten, Kämpfe, Dietrich, Jentsch-Ullrich, Kathleen, Junghanss, Christian, Nowak, Ralf, Schwarzer, Andreas, Spohn, Claudia, Vucinic, Vladan, Hochhaus, Andreas, Lange, Thoralf, and For the Working Party Myeloproliferative Neoplasms of the East German Study Group Hematology/Oncology (OSHO)

Published
2018
Full Text
View/download PDF

42. BOREAS: a global, phase III study of the MDM2 inhibitor navtemadlin (KRT-232) in relapsed/refractory myelofibrosis

Author

Verstovsek, Srdan, primary, Al-Ali, Haifa Kathrin, additional, Mascarenhas, John, additional, Perkins, Andrew, additional, Vannucchi, Alessandro Maria, additional, Mohan, Sanjay R, additional, Scott, Bart L, additional, Woszczyk, Dariusz, additional, Koschmieder, Steffen, additional, García-Delgado, Regina, additional, László, Rejtő, additional, McGreivy, Jesse S, additional, Rothbaum, Wayne P, additional, and Kiladjian, Jean-Jacques, additional

Published
2022
Full Text
View/download PDF

43. Long-Term Efficacy and Safety of Luspatercept for Anemia Treatment in Patients With Lower-Risk Myelodysplastic Syndromes: The Phase II PACE-MDS Study

Author

Platzbecker, Uwe, primary, Götze, Katharina S., additional, Kiewe, Philipp, additional, Germing, Ulrich, additional, Mayer, Karin, additional, Radsak, Markus, additional, Wolff, Thomas, additional, Chromik, Joerg, additional, Sockel, Katja, additional, Oelschlägel, Uta, additional, Haase, Detlef, additional, Illmer, Thomas, additional, Al-Ali, Haifa Kathrin, additional, Silling, Gerda, additional, Reynolds, Joseph G., additional, Zhang, Xiaosha, additional, Attie, Kenneth M., additional, Shetty, Jeevan K., additional, and Giagounidis, Aristoteles, additional

Published
2022
Full Text
View/download PDF

44. Updated Results from the Momentum Phase 3 Study of Momelotinib (MMB) Versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated with a JAK Inhibitor

Author

Gerds, Aaron T., primary, Mesa, Ruben, additional, Vannucchi, Alessandro M, additional, Al-Ali, Haifa Kathrin, additional, Lavie, David, additional, Kuykendall, Andrew, additional, Grosicki, Sebastian, additional, Iurlo, Alessandra, additional, Goh, Yeow Tee, additional, Lazaroiu, Mihaela, additional, Egyed, Miklos, additional, Fox, Maria Laura, additional, McLornan, Donal P., additional, Perkins, Andrew Charles, additional, Yoon, Sung-Soo, additional, Gupta, Vikas, additional, Kiladjian, Jean-Jacques, additional, Donahue, Rafe, additional, Kawashima, Jun, additional, and Verstovsek, Srdan, additional

Published
2022
Full Text
View/download PDF

45. Increased LFS Following Hematopoietic Cell Transplantation As Compared to Conventional Consolidation Therapy in Patients >60 Years with AML in First Complete Remission and a Matched Donor: Results of a Randomized Phase III Study

Author

Niederwieser, Dietger, primary, Hasenclever, Dirk, additional, Berdel, Wolfgang E., additional, Biemond, Bart J., additional, Al-Ali, Haifa Kathrin, additional, Chalandon, Yves, additional, Van Gelder, Michel, additional, Junghanss, Christian, additional, Gahrton, Goesta, additional, Haenel, Mathias, additional, Hehlmann, Rüdiger, additional, Heinicke, Thomas, additional, Hochhaus, Andreas, additional, Iacobelli, Simona, additional, Kooy, Rien van Marwijk, additional, Kröger, Nicolaus, additional, Janssen, Jeroen J.W.M., additional, Jentzsch, Madlen, additional, Breywisch, Frank, additional, Mohty, Mohamad, additional, Masouridi-Levrat, Stavroula, additional, Ossenkoppele, Gert, additional, Passweg, Jakob, additional, Pönisch, Wolfram, additional, Schetelig, Johannes, additional, Schliemann, Christoph, additional, Schwind, Sebastian, additional, Stelljes, Matthias, additional, Valk, Peter JM, additional, Lowenberg, Bob, additional, and Cornelissen, Jan J., additional

Published
2022
Full Text
View/download PDF

46. Protection Against Breakthrough Delta/Omicron Variants in Vaccinated Patients with Myeloproliferative Neoplasms (MPN)

Author

Barbui, Tiziano, primary, Carobbio, Alessandra, additional, Ghirardi, Arianna, additional, Iurlo, Alessandra, additional, De Stefano, Valerio, additional, Sobas, Marta Anna, additional, Rumi, Elisa, additional, Elli, Elena Maria, additional, Lunghi, Francesca, additional, Gasior Kabat, Mercedes, additional, Cuevas, Beatriz, additional, Guglielmelli, Paola, additional, Bonifacio, Massimiliano, additional, Marchetti, Monia, additional, Alvarez-Larran, Alberto, additional, Fox, Laura Maria, additional, Bellini, Marta, additional, Daffini, Rosa, additional, Benevolo, Giulia, additional, Carreño, Gonzalo, additional, Patriarca, Andrea, additional, Al-Ali, Haifa Kathrin, additional, Andrade, Marcio, additional, Palandri, Francesca, additional, Harrison, Claire, additional, Foncillas, Maria Angeles, additional, Osorio, Santiago, additional, Koschmieder, Steffen, additional, Magro, Elena, additional, Kiladjian, Jean-Jacques, additional, Bolaños, Estefanía, additional, Heidel, Florian H., additional, Quiroz, Keina, additional, Griesshammer, Martin, additional, García Gutiérrez, Valentín, additional, Marin Sanchez, Alberto, additional, Hernandez Boluda, Juan Carlos, additional, Lopez Abadia, Emma, additional, Carli, Giuseppe, additional, Sagüés, Miguel, additional, Kusec, Rajko, additional, Xicoy, Blanca, additional, Guenova, Margarita, additional, Navas, Begoña, additional, Angona, Anna, additional, Cichocka, Edyta, additional, Masternak, Anna, additional, Cattaneo, Daniele, additional, Bucelli, Cristina, additional, Betti, Silvia, additional, Borsani, Oscar, additional, Cavalca, Fabrizio, additional, Carbonell, Sara, additional, Curto-Garcia, Natalia, additional, Benajiba, Lina, additional, Rambaldi, Alessandro, additional, and Vannucchi, Alessandro M., additional

Published
2022
Full Text
View/download PDF

47. Transfusion Independence Response As a Potential Surrogate for Overall Survival in Jaki-Experienced Patients with Myelofibrosis from Momentum

Author

Verstovsek, Srdan, primary, Oh, Stephen T, additional, Kiladjian, Jean-Jacques, additional, Platzbecker, Uwe, additional, Passamonti, Francesco, additional, Gerds, Aaron T., additional, Vannucchi, Alessandro M, additional, McLornan, Donal P., additional, Gupta, Vikas, additional, Grosicki, Sebastian, additional, Al-Ali, Haifa Kathrin, additional, Lavie, David, additional, Kuykendall, Andrew, additional, Lee, Sung-Eun, additional, Iurlo, Alessandra, additional, Ocroteala, Luminita, additional, Kawashima, Jun, additional, Donahue, Rafe, additional, Strouse, Bryan, additional, and Mesa, Ruben, additional

Published
2022
Full Text
View/download PDF

48. Risk‐adjusted safety analysis of the oral JAK2/IRAK1 inhibitor pacritinib in patients with myelofibrosis

Author

Pemmaraju, Naveen, primary, Harrison, Claire, additional, Gupta, Vikas, additional, Verstovsek, Srdan, additional, Scott, Bart, additional, Oh, Stephen T., additional, Palandri, Francesca, additional, Al‐Ali, Haifa Kathrin, additional, Sobas, Marta, additional, McMullin, Mary Frances, additional, Mesa, Ruben, additional, Buckley, Sarah, additional, Roman‐Torres, Karisse, additional, Vannucchi, Alessandro, additional, and Yacoub, Abdulraheem, additional

Published
2022
Full Text
View/download PDF

49. Poster: MPN-478 MOMENTUM: Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) in Symptomatic and Anemic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor

Author

Mesa, Ruben, primary, Gerds, Aaron, additional, Vannucchi, Alessandro, additional, Al-Ali, Haifa Kathrin, additional, Lavie, David, additional, Kuykendall, Andrew, additional, Grosicki, Sebastian, additional, Iurlo, Alessandra, additional, Goh, Yeow Tee, additional, Lazaroiu, Mihaela, additional, Egyed, Miklos, additional, Fox, Maria Laura, additional, McLornan, Donal, additional, Perkins, Andrew, additional, Yoon, Sung-Soo, additional, Gupta, Vikas, additional, Kiladjian, Jean-Jacques, additional, Donahue, Rafe, additional, Kawashima, Jun, additional, and Verstovsek, Srdan, additional

Published
2022
Full Text
View/download PDF

50. Poster: MPN-483 Thrombocytopenic Myelofibrosis (MF) Patients Previously Treated With a JAK Inhibitor in a Phase 3 Randomized Study of Momelotinib (MMB) versus Danazol (DAN) [MOMENTUM]

Author

Gerds, Aaron, primary, Verstovsek, Srdan, additional, Vannucchi, Alessandro, additional, Al-Ali, Haifa Kathrin, additional, Lavie, David, additional, Kuykendall, Andrew, additional, Grosicki, Sebastian, additional, Iurlo, Alessandra, additional, Goh, Yeow Tee, additional, Lazaroiu, Mihaela, additional, Egyed, Miklos, additional, Fox, Maria Laura, additional, McLornan, Donal, additional, Perkins, Andrew, additional, Yoon, Sung-Soo, additional, Gupta, Vikas, additional, Kiladjian, Jean-Jacques, additional, Donahue, Rafe, additional, Kawashima, Jun, additional, and Mesa, Ruben, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results